Genomic Classification of Acute Lymphoblastic Leukemia Using AI: Towards Personalized Medicine

Acute lymphoblastic leukemia is a highly heterogeneous hematologic malignancy that poses significant challenges for clinicians in terms of early detection and accurate subtype classification. Misclassification or delayed recognition of molecular subtypes can lead to suboptimal treatment decisions and negatively impact patient outcomes. Traditional diagnostic methods, while effective, often lack the sensitivity to fully capture the underlying molecular diversity of acute lymphoblastic leukemia. In this study, we applied an artificial intelligence-driven diagnostic framework to analyze gene expression profiles of patients with acute lymphoblastic leukemia. By leveraging advanced computational techniques, the model was able to identify distinct molecular signatures and stratify patients according to their genomic subtypes. The findings demonstrate that AI-assisted genomic classification has the potential to enhance diagnostic precision and enable earlier identification of clinically relevant subgroups. This approach may support more tailored therapeutic strategies and represents an important step toward the integration of precision medicine in the management of acute lymphoblastic leukemia.